Advertisement

Diabetes Type 2

 
Study: Bariatric Surgery Linked to Significant Decrease in Mortality at 40-year Follow-up
January 27, 2023

A pivotal study with 40-year follow-up of post-bariatric surgery patients reinforces long-term benefits of the procedures on all-cause and cause-specific mortality.

Daily Dose: Improved Glycemic Control and NAFLD in Type 2 Diabetes
January 24, 2023

Your daily dose of clinical news you may have missed.

FDA Approves SGLT2 Inhibitor Bexagliflozin to Treat Type 2 Diabetes in Adults
January 23, 2023

Bexagliflozin significantly improved glycemic control in adults when used as monotherapy, in combination with metformin, or when added to several SOC regimens.

Improved HbA1c in Adults with T2D Had Beneficial Impact on NAFLD, According to New Study
January 23, 2023

Adults with T2D may be able to reduce their liver fat and improve their liver fibrosis stage with reductions in HbA1c, according to findings from a retrospective analysis.

Metformin Treatment in T2D Patients May Reduce Risk for Joint Replacement: Population-based Study
January 23, 2023

Investigators report a 30% reduced risk of total joint replacement in persons with type 2 diabetes treated with metformin vs those who did not receive the drug.

FDA Approves Label Update for Semaglutide as a First-line Type 2 Diabetes Medication
January 16, 2023

The update removes a previous limitation that stated semaglutide should not be used as an initial therapy for treating patients with T2D.

Diabetes in US Youth Projected to Surge Dangerously by 2060
January 12, 2023

Diabetes cases in the US among those younger than age 20 years, if left unchecked, are projected to increase by more than 600% by 2060, according to new projections.

Osteoporosis May Affect More than One-quarter of Persons with Type 2 Diabetes: Global Meta-analysis
January 11, 2023

A global prevalence of osteoporosis among persons with T2D of more than 25% calls for greater focus on screening for and managing the bone loss disease in this population.

Greater Glycemic Control May Impact Biological Aging in Adults with Type 2 Diabetes
January 06, 2023

Optimal glycemic control (less than 7%) in participants from the Look AHEAD trial was associated with smaller increases in frailty index score vs poorer control over the 8-year study period.

Type 2 Diabetes: Top Papers in 2022
December 28, 2022

Find a compact sampling of 2022 research on type 2 diabetes and its treatment reviewed on Patient Care, chosen by the editorial staff.

Advertisement
Advertisement